Invitae Analyst Ratings
Invitae Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | -53.7% | Piper Sandler | $1.5 → $0.5 | Maintains | Underweight |
| 07/24/2023 | -7.41% | Goldman Sachs | $1.5 → $1 | Maintains | Sell |
| 07/21/2023 | -7.41% | Goldman Sachs | $1.5 → $1 | Maintains | Sell |
| 05/15/2023 | — | Raymond James | Downgrades | Market Perform → Underperform | |
| 05/11/2023 | 38.89% | Goldman Sachs | $2 → $1.5 | Maintains | Sell |
| 03/03/2023 | 62.04% | Piper Sandler | $2.25 → $1.75 | Maintains | Underweight |
| 01/31/2023 | 85.19% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 11/09/2022 | 177.78% | SVB Leerink | $2.5 → $3 | Maintains | Market Perform |
| 08/25/2022 | -7.41% | Credit Suisse | → $1 | Initiates Coverage On | → Underperform |
| 08/18/2022 | 108.33% | Piper Sandler | $2.5 → $2.25 | Maintains | Underweight |
| 08/10/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 08/10/2022 | 131.48% | SVB Leerink | $2 → $2.5 | Maintains | Market Perform |
| 07/26/2022 | 131.48% | Cowen & Co. | $8 → $2.5 | Downgrades | Outperform → Market Perform |
| 07/21/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 07/19/2022 | 640.74% | Cowen & Co. | $10 → $8 | Maintains | Outperform |
| 07/19/2022 | — | Benchmark | Downgrades | Buy → Hold | |
| 07/19/2022 | 85.19% | SVB Leerink | $8 → $2 | Downgrades | Outperform → Market Perform |
| 06/13/2022 | 455.56% | Benchmark | $13 → $6 | Maintains | Buy |
| 06/03/2022 | 131.48% | Piper Sandler | → $2.5 | Initiates Coverage On | → Underweight |
| 05/05/2022 | 687.04% | Raymond James | $10.5 → $8.5 | Maintains | Outperform |
| 05/04/2022 | 1474.07% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight |
| 04/19/2022 | 825.93% | Goldman Sachs | $14 → $10 | Maintains | Neutral |
| 04/18/2022 | 872.22% | Raymond James | $15 → $10.5 | Maintains | Outperform |
| 02/28/2022 | 1288.89% | Raymond James | $36 → $15 | Maintains | Outperform |
| 02/25/2022 | 2214.81% | SVB Leerink | $30 → $25 | Maintains | Outperform |
| 02/15/2022 | 1566.67% | Morgan Stanley | $37 → $18 | Maintains | Equal-Weight |
| 11/09/2021 | 3233.33% | Raymond James | $38 → $36 | Maintains | Outperform |
| 08/05/2021 | 3603.7% | Morgan Stanley | $41 → $40 | Maintains | Equal-Weight |
| 08/04/2021 | 3140.74% | Benchmark | → $35 | Upgrades | Hold → Buy |
| 06/21/2021 | 3140.74% | Wells Fargo | $30 → $35 | Maintains | Equal-Weight |
| 06/15/2021 | 3325.93% | Raymond James | → $37 | Initiates Coverage On | → Outperform |
| 06/03/2021 | 2955.56% | Goldman Sachs | → $33 | Initiates Coverage On | → Neutral |
| 05/25/2021 | 2677.78% | Wells Fargo | → $30 | Initiates Coverage On | → Equal-Weight |
| 05/06/2021 | 3696.3% | Morgan Stanley | $45 → $41 | Maintains | Equal-Weight |
| 05/05/2021 | 4529.63% | SVB Leerink | $65 → $50 | Maintains | Outperform |
| 04/05/2021 | 4344.44% | Oppenheimer | → $48 | Upgrades | Perform → Outperform |
| 02/22/2021 | 4066.67% | Morgan Stanley | $41 → $45 | Maintains | Equal-Weight |
| 02/19/2021 | 4066.67% | Morgan Stanley | $41 → $45 | Maintains | Equal-Weight |
| 02/18/2021 | 5270.37% | Ladenburg Thalmann | $46.5 → $58 | Upgrades | Neutral → Buy |
| 02/18/2021 | 5918.52% | SVB Leerink | $64 → $65 | Maintains | Outperform |
| 02/01/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 01/20/2021 | 5825.93% | SVB Leerink | $48 → $64 | Maintains | Outperform |
| 11/06/2020 | 3696.3% | Morgan Stanley | $38 → $41 | Maintains | Equal-Weight |
| 11/06/2020 | 4344.44% | SVB Leerink | $44 → $48 | Maintains | Outperform |
| 11/03/2020 | 3974.07% | SVB Leerink | $34 → $44 | Maintains | Outperform |
| 10/14/2020 | 4066.67% | JP Morgan | → $45 | Downgrades | Overweight → Neutral |
| 09/09/2020 | 3418.52% | Morgan Stanley | → $38 | Initiates Coverage On | → Equal-Weight |
| 08/05/2020 | 3048.15% | SVB Leerink | $40 → $34 | Maintains | Outperform |
| 07/15/2020 | 3603.7% | SVB Leerink | $25 → $40 | Maintains | Outperform |
| 07/01/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 05/06/2020 | 2214.81% | SVB Leerink | $20 → $25 | Maintains | Outperform |
| 04/08/2020 | 1751.85% | Benchmark | $31 → $20 | Maintains | Buy |
| 03/04/2019 | — | Chardan Capital | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月15日 | -53.7% | 派珀·桑德勒 | $1.5→$0.5 | 維護 | 體重不足 |
| 07/24/2023 | -7.41% | 高盛 | $1.5→$1 | 維護 | 賣 |
| 07/21/2023 | -7.41% | 高盛 | $1.5→$1 | 維護 | 賣 |
| 2023年05月15日 | - | 雷蒙德·詹姆斯 | 評級下調 | 市場表現→表現不佳 | |
| 2023年05月11日 | 38.89% | 高盛 | $2→$1.5 | 維護 | 賣 |
| 03/03/2023 | 62.04% | 派珀·桑德勒 | $2.25→$1.75 | 維護 | 體重不足 |
| 2023年年1月31日 | 85.19% | 高盛 | →$2 | 評級下調 | 中性→銷售 |
| 11/09/2022 | 177.78% | SVB Leerink | $2.5→$3 | 維護 | 市場表現 |
| 2022年08月25日 | -7.41% | 瑞士信貸 | →$1 | 開始承保 | →表現不佳 |
| 2022/08/18 | 108.33% | 派珀·桑德勒 | $2.5→$2.25 | 維護 | 體重不足 |
| 2022年08月10日 | - | 摩根大通 | 評級下調 | 中性→減持 | |
| 2022年08月10日 | 131.48% | SVB Leerink | $2→$2.5 | 維護 | 市場表現 |
| 07/26/2022 | 131.48% | 考恩公司 | $8→$2.5 | 評級下調 | 跑贏→市場表現 |
| 07/21/2022 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
| 07/19/2022 | 640.74% | 考恩公司 | $10→$8 | 維護 | 跑贏大盤 |
| 07/19/2022 | - | 基準 | 評級下調 | 購買→Hold | |
| 07/19/2022 | 85.19% | SVB Leerink | $8→$2 | 評級下調 | 跑贏→市場表現 |
| 2022/06/13 | 455.56% | 基準 | $13→$6 | 維護 | 買 |
| 06/03/2022 | 131.48% | 派珀·桑德勒 | →$2.5 | 開始承保 | →減持 |
| 05/05/2022 | 687.04% | 雷蒙德·詹姆斯 | $10.5→$8.5 | 維護 | 跑贏大盤 |
| 05/04/2022 | 1474.07% | 摩根士丹利 | $18→$17 | 維護 | 等重 |
| 04/19/2022 | 825.93% | 高盛 | $14→$10 | 維護 | 中性 |
| 04/18/2022 | 872.22% | 雷蒙德·詹姆斯 | $15→$10.5 | 維護 | 跑贏大盤 |
| 02/28/2022 | 1288.89% | 雷蒙德·詹姆斯 | $36→$15 | 維護 | 跑贏大盤 |
| 02/25/2022 | 2214.81% | SVB Leerink | $30→$25 | 維護 | 跑贏大盤 |
| 02/15/2022 | 1566.67% | 摩根士丹利 | $37→$18 | 維護 | 等重 |
| 11/09/2021 | 3233.33% | 雷蒙德·詹姆斯 | $38→$36 | 維護 | 跑贏大盤 |
| 08/05/2021 | 3603.7% | 摩根士丹利 | $41→$40 | 維護 | 等重 |
| 08/04/2021 | 3140.74% | 基準 | →$35 | 升級 | 持有→購買 |
| 2021/06/21 | 3140.74% | 富國銀行 | $30→$35 | 維護 | 等重 |
| 2021/06/15 | 3325.93% | 雷蒙德·詹姆斯 | →$37 | 開始承保 | →跑贏大盤 |
| 06/03/2021 | 2955.56% | 高盛 | →$33 | 開始承保 | →中性 |
| 2021/05/25 | 2677.78% | 富國銀行 | →$30 | 開始承保 | →等重 |
| 05/06/2021 | 3696.3% | 摩根士丹利 | $45→$41 | 維護 | 等重 |
| 05/05/2021 | 4529.63% | SVB Leerink | $65→$50 | 維護 | 跑贏大盤 |
| 04/05/2021 | 4344.44% | 奧本海默 | →$48 | 升級 | →表現強於大盤 |
| 02/22/2021 | 4066.67% | 摩根士丹利 | $41→$45 | 維護 | 等重 |
| 02/19/2021 | 4066.67% | 摩根士丹利 | $41→$45 | 維護 | 等重 |
| 02/18/2021 | 5270.37% | 拉登堡·塔爾曼 | $46.5→$58 | 升級 | 中性→購買 |
| 02/18/2021 | 5918.52% | SVB Leerink | $64→$65 | 維護 | 跑贏大盤 |
| 02/01/2021 | - | 奧本海默 | 評級下調 | 超越→表現 | |
| 01/20/2021 | 5825.93% | SVB Leerink | $48→$64 | 維護 | 跑贏大盤 |
| 11/06/2020 | 3696.3% | 摩根士丹利 | $38→$41 | 維護 | 等重 |
| 11/06/2020 | 4344.44% | SVB Leerink | $44→$48 | 維護 | 跑贏大盤 |
| 11/03/2020 | 3974.07% | SVB Leerink | $34→$44 | 維護 | 跑贏大盤 |
| 10/14/2020 | 4066.67% | 摩根大通 | →$45 | 評級下調 | 超重→中性 |
| 09/09/2020 | 3418.52% | 摩根士丹利 | →$38 | 開始承保 | →等重 |
| 08/05/2020 | 3048.15% | SVB Leerink | $40→$34 | 維護 | 跑贏大盤 |
| 07/15/2020 | 3603.7% | SVB Leerink | $25→$40 | 維護 | 跑贏大盤 |
| 07/01/2020 | - | 基準 | 評級下調 | 購買→Hold | |
| 05/06/2020 | 2214.81% | SVB Leerink | $20→$25 | 維護 | 跑贏大盤 |
| 04/08/2020 | 1751.85% | 基準 | $31→$20 | 維護 | 買 |
| 2019/03/04 | - | 查爾丹資本 | 開始承保 | →購買 |
What is the target price for Invitae (NVTA)?
Invitae(NVTA)的目標價是多少？
The latest price target for Invitae (NYSE: NVTA) was reported by Piper Sandler on August 15, 2023. The analyst firm set a price target for $0.50 expecting NVTA to fall to within 12 months (a possible -53.70% downside). 10 analyst firms have reported ratings in the last year.
Piper Sandler於2023年8月15日報道了Invitae(紐約證券交易所代碼：NVTA)的最新目標價。這家分析公司將NVTA的目標價設定為0.50美元，預計NVTA將在12個月內跌至(可能下跌-53.70%)。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Invitae (NVTA)?
Invitae(NVTA)的最新分析師評級是多少？
The latest analyst rating for Invitae (NYSE: NVTA) was provided by Piper Sandler, and Invitae maintained their underweight rating.
Piper Sandler對Invitae(紐約證券交易所代碼：NVTA)的最新分析師評級是由Piper Sandler提供的，Invitae維持其減持評級。
When is the next analyst rating going to be posted or updated for Invitae (NVTA)?
Invitae(NVTA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invitae, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invitae was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Invitae的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Invitae的上一次評級是在2023年8月15日提交的，所以你應該預計下一次評級將在2024年8月15日左右提供。
Is the Analyst Rating Invitae (NVTA) correct?
分析師評級邀請函(NVTA)正確嗎？
While ratings are subjective and will change, the latest Invitae (NVTA) rating was a maintained with a price target of $1.50 to $0.50. The current price Invitae (NVTA) is trading at is $1.08, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Invitae(NVTA)評級維持不變，目標價在1.50美元至0.50美元之間。目前Invitae(NVTA)的交易價格為1.08美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。